"The Impact of Emerging Safety and Effectiveness Evidence on the Use of Physician-administered Drugs: The Case of Bevacizumab for Breast Cancer."

Conti, Rena M., Stacie B. Dusetzina, Ann C. Herbert, Ernst R. Berndt, Haiden A. Huskamp and Nancy L. Keating. Medical Care Vol. 51, No. 7 (2013): 622-627.

"How Quickly Do Physicians Adopt New Drugs? The Case of Antipsychotics."

Huskamp, Haiden A., Alistar J. O’Malley, Marcela Horvitz-Lennon, Anna Levine Taub, Ernst R. Berndt and Julie M. Donohue. Psychiatric Services Vol. 64, No. 4 (2013): 324-330.

"Promotion of Prescription Drugs to Consumers and Providers, 2001-2010."

Kornfield, Rachel, Julie Donohue, Ernst R. Berndt and G. Caleb Alexander. PLoS ONE Vol. 8, No. 3 (2013): 1-7.

"Uncertain Prognosis for high-quality Diagnostics: Clinical Challenges, Economic Barriers and Needed Reforms."

Trusheim, Mark R., M.J. Finley Austin, Carsten Rausch and Ernst R. Berndt. Pharmacogenomics Vol. 14, No. 3 (2013): 325-334.

"Winners and Losers From the Zaltrap Price Discount: Unintended Consequences?"

Conti, Rena M. and Ernst R. Berndt. Health Affairs Blog. Project Hope, February 2013.

"Economic Challenges and Possible Policy Actions to Advance Stratified Medicine."

Trusheim, Mark R. and Ernst R.Berndt. Personalized Medicine Vol. 9, No. 4 (2012): 413-427.